product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
human PYK2/FAK2 (NP_004094.3) VersaClone cDNA
catalog :
RDC3626
quantity :
10 ug
price :
643 USD
more info or order :
image
image 1 :

product information
master code :
RDC3626
SKU :
RDC3626
product name :
human PYK2/FAK2 (NP_004094.3) VersaClone cDNA
unit size :
10 ug
description :
R&D Systems human PYK2/FAK2 (NP_004094.3) VersaClone cDNA clone contains the complete ORF for PYK2/FAK2, along with a Kozak consensus sequence for optimal translation initiation. The gene insert is flanked with convenient multiple cloning sites which can be used to easily cut and transfer the gene cassette into your desired expression vector. The PYK2/FAK2 insert is sequence verified and the entire plasmid DNA and insert translated sequences are provided.
target :
PYK2/FAK2
category :
cDNA Clones
accessionNumbers :
NP_004094.3
USD :
643 USD
alt names :
CADTK, CADTKCAK-beta, CAK beta, CAKB, Calcium-dependent tyrosine kinase, Cell adhesion kinase beta, EC 2.7.10, FADK2, FAK2, FAK2EC 2.7.10.2, Focal adhesion kinase 2, FRNK, PKB, ppyk2, Proline-rich tyrosine kinase 2, protein kinase B, protein tyrosine kinase 2 beta, protein-tyrosine kinase 2-beta, PTK, PTK2B, PTK2B protein tyrosine kinase 2 beta, PYK2Related adhesion focal tyrosine kinase, RAFTK, RAFTKFADK 2
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments